Mesalamine Controlled-Release Capsules and Remifentanil Intravenous
Determining the interaction of Mesalamine Controlled-Release Capsules and Remifentanil Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: mesalamine
Brand name: Apriso, Asacol HD, Delzicol, Lialda, Pentasa, Canasa, Canasa Pac, Rowasa, SfRowasa
Synonyms: Mesalamine
Generic Name: remifentanil
Brand name: Ultiva
Synonyms: Remifentanil
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Mesalamine Controlled-Release Capsules-Reminyl
- Mesalamine Controlled-Release Capsules-Reminyl ER
- Mesalamine Controlled-Release Capsules-Remodulin
- Mesalamine Controlled-Release Capsules-Remodulin injection
- Mesalamine Controlled-Release Capsules-Remular-S
- Mesalamine Controlled-Release Capsules-Renacidin
- Remifentanil Intravenous-Mesalamine Delayed Release Tablets
- Remifentanil Intravenous-Mesalamine Long-Acting Capsules (Apriso)
- Remifentanil Intravenous-Mesalamine Long-Acting Capsules (Delzicol)
- Remifentanil Intravenous-Mesalamine Long-Acting Capsules (Pentasa)
- Remifentanil Intravenous-Mesalamine rectal
- Remifentanil Intravenous-Mesalamine Rectal Enema